BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bridges JF, Gallego G, Kudo M, Okita K, Han KH, Ye SL, Blauvelt BM. Identifying and prioritizing strategies for comprehensive liver cancer control in Asia. BMC Health Serv Res 2011;11:298. [PMID: 22047535 DOI: 10.1186/1472-6963-11-298] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Wong MCS, Huang JLW, George J, Huang J, Leung C, Eslam M, Chan HLY, Ng SC. The changing epidemiology of liver diseases in the Asia–Pacific region. Nat Rev Gastroenterol Hepatol 2019;16:57-73. [DOI: 10.1038/s41575-018-0055-0] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 30.8] [Reference Citation Analysis]
2 Fashoyin-Aje L, Sanghavi K, Bjornard K, Bodurtha J. Integrating genetic and genomic information into effective cancer care in diverse populations. Ann Oncol 2013;24 Suppl 7:vii48-54. [PMID: 24001763 DOI: 10.1093/annonc/mdt264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Hollin IL, Craig BM, Coast J, Beusterien K, Vass C, Disantostefano R, Peay H. Reporting Formative Qualitative Research to Support the Development of Quantitative Preference Study Protocols and Corresponding Survey Instruments: Guidelines for Authors and Reviewers. Patient 2020;13:121-36. [DOI: 10.1007/s40271-019-00401-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
4 de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA. Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide. Patient 2015;8:373-84. [PMID: 25726010 DOI: 10.1007/s40271-015-0118-z] [Cited by in Crossref: 232] [Cited by in F6Publishing: 209] [Article Influence: 38.7] [Reference Citation Analysis]
5 Schuster AL, Aslakson RA, Bridges JF. Creating an advance-care-planning decision aid for high-risk surgery: a qualitative study. BMC Palliat Care 2014;13:32. [PMID: 25067908 DOI: 10.1186/1472-684X-13-32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
6 Bao Y, Wang S, Yang X, Li T, Xia Y, Meng X. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS. J Ethnopharmacol 2017;198:468-78. [PMID: 28108381 DOI: 10.1016/j.jep.2017.01.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
7 Bridges JF, Joy SM, Blauvelt BM, Yan W, Marsteller JA. An international comparison of stakeholder motivation to implement liver cancer control. Health Policy Plan 2015;30:645-55. [PMID: 24974105 DOI: 10.1093/heapol/czu044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Sigurdson S, Harrison M, Pearce A, Richardson H, Zaza K, Brundage M. One Fraction Size Does Not Fit All: Patient Preferences for Hypofractionated Radiation Therapy From a Discrete Choice Experiment. Pract Radiat Oncol 2022;12:e24-33. [PMID: 34991857 DOI: 10.1016/j.prro.2021.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bridges JF, Dong L, Gallego G, Blauvelt BM, Joy SM, Pawlik TM. Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis. BMC Health Serv Res 2012;12:376. [PMID: 23110423 DOI: 10.1186/1472-6963-12-376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
10 Gouglas D, Hoyt K, Peacocke E, Kaloudis A, Ottersen T, Røttingen J. Setting Strategic Objectives for the Coalition for Epidemic Preparedness Innovations: An Exploratory Decision Analysis Process. INFORMS Journal on Applied Analytics 2019;49:430-46. [DOI: 10.1287/inte.2019.1011] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Vass C, Rigby D, Payne K. The Role of Qualitative Research Methods in Discrete Choice Experiments. Med Decis Making 2017;37:298-313. [PMID: 28061040 DOI: 10.1177/0272989X16683934] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 10.2] [Reference Citation Analysis]
12 Joy SM, Blauvelt BM, Tuncer MA, Beaugrand M, Sangro B, Colombo M, Bridges JF. Stakeholder perspectives on European priorities for comprehensive liver cancer control: a conjoint analysis. Eur J Public Health 2013;23:951-7. [PMID: 23531524 DOI: 10.1093/eurpub/cks173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Bridges JF, Joy SM, Gallego G, Blauvelt BM, Geschwind JH, Pawlik TM. Priorities for Hepatocellular Carcinoma (HCC) Control: A Comparison of Policy Needs in Five European Countries. Journal of Comparative Policy Analysis: Research and Practice 2012;14:352-68. [DOI: 10.1080/13876988.2012.698581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]